Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lloyd J Old

Showing results (11-20 of 245) with videos related to

Pageof 25
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2009
Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccinationTakemasa Tsuji, Nasser K Altorki, Gerd Ritter, et al.
International Journal of Cancer|September 7, 2002
The SSX gene family: characterization of 9 complete genesAli O Güre, Isaac J Wei, Lloyd J Old, et al.
Clinical Immunology (Orlando, Fla.)|August 17, 2005
Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4+ T cells in cancer-free individualsDanila Valmori, Naira E Souleimanian, Charles S Hesdorffer, et al.
Cancer Research|April 19, 2005
IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expressionGavin P Dunn, Kathleen C F Sheehan, Lloyd J Old, et al.
Nature|May 28, 2004
Oncogenomics and the development of new cancer therapiesRobert L Strausberg, Andrew J G Simpson, Lloyd J Old, et al.
Human Reproduction (Oxford, England)|October 22, 2011
Chromosome X-encoded cancer/testis antigens show distinctive expression patterns in developing gonads and in testicular seminomaYao-Tseng Chen, Rita Chiu, Peishan Lee, et al.
Gene|October 18, 2002
A new member of the NY-ESO-1 gene family is ubiquitously expressed in somatic tissues and evolutionarily conservedBirgit Alpen, Ali O Güre, Matthew J Scanlan, et al.
Nature Immunology|October 31, 2002
Cancer immunoediting: from immunosurveillance to tumor escapeGavin P Dunn, Allen T Bruce, Hiroaki Ikeda, et al.
Nature Reviews. Cancer|July 22, 2005
Cancer/testis antigens, gametogenesis and cancerAndrew J G Simpson, Otavia L Caballero, Achim Jungbluth, et al.
Cancer Immunology Research|April 26, 2014
Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cellsJunko Matsuzaki, Takemasa Tsuji, Immanuel Luescher, et al.
Pageof 25

Showing results (11-20 of 245) with videos related to

Sort By:
Pageof 25
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2009
Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccinationTakemasa Tsuji, Nasser K Altorki, Gerd Ritter, et al.
International Journal of Cancer|September 7, 2002
The SSX gene family: characterization of 9 complete genesAli O Güre, Isaac J Wei, Lloyd J Old, et al.
Clinical Immunology (Orlando, Fla.)|August 17, 2005
Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4+ T cells in cancer-free individualsDanila Valmori, Naira E Souleimanian, Charles S Hesdorffer, et al.
Cancer Research|April 19, 2005
IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expressionGavin P Dunn, Kathleen C F Sheehan, Lloyd J Old, et al.
Nature|May 28, 2004
Oncogenomics and the development of new cancer therapiesRobert L Strausberg, Andrew J G Simpson, Lloyd J Old, et al.
Human Reproduction (Oxford, England)|October 22, 2011
Chromosome X-encoded cancer/testis antigens show distinctive expression patterns in developing gonads and in testicular seminomaYao-Tseng Chen, Rita Chiu, Peishan Lee, et al.
Gene|October 18, 2002
A new member of the NY-ESO-1 gene family is ubiquitously expressed in somatic tissues and evolutionarily conservedBirgit Alpen, Ali O Güre, Matthew J Scanlan, et al.
Nature Immunology|October 31, 2002
Cancer immunoediting: from immunosurveillance to tumor escapeGavin P Dunn, Allen T Bruce, Hiroaki Ikeda, et al.
Nature Reviews. Cancer|July 22, 2005
Cancer/testis antigens, gametogenesis and cancerAndrew J G Simpson, Otavia L Caballero, Achim Jungbluth, et al.
Cancer Immunology Research|April 26, 2014
Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cellsJunko Matsuzaki, Takemasa Tsuji, Immanuel Luescher, et al.
Pageof 25